Clinical characteristics of mephedrone toxicity reported to the UK National Poisons Information Service

Abstract

ObjectiveTo describe the patterns and clinical features of toxicity related to recreational use of mephedrone and other cathinones in the UK using data collected by the National Poisons Information Service (NPIS).MethodsThe number of accesses to TOXBASE, the NPIS online poisons information database, details of consecutive cases uploaded onto TOXBASE and the number and details of telephone enquiries made to the NPIS by health professionals in the UK were collected for the period March 2009 to February 2010.ResultsOver the year of study there were 2901 TOXBASE accesses and 188 telephone enquiries relating to cathinones, the majority relating to mephedrone (TOXBASE 1664, telephone 157), with a month-on-month increase in numbers. In 131 telephone enquiries concerning mephedrone, alone or in combination with alcohol, common clinical features reported included agitation or aggression (n=32, 24%, 95% CI 18% to 33%), tachycardia (n=29, 22%, 95% CI 16% to 30%), confusion or psychosis (n=18, 14%, 95% CI 9% to 21%), chest pain (n=17, 13%, 95% CI 8% to 20%), nausea (n=15, 11%, 95% CI 7% to 18%), palpitations (n=14, 11%, 95% CI 6% to 18%), peripheral vasoconstriction (n=10, 8%, 95% CI 4% to 14%) and headache (n=7, 5%, 95% CI 2% to 11%). Convulsions were reported in four cases (3%, 95% CI 1% to 8%). One exposed person died following cardiac arrest (1%, 95% CI 0% to 4%), although subsequent investigation suggested that mephedrone was not responsible.ConclusionsToxicity associated with recreational mephedrone use is increasingly common in the UK. Sympathomimetic adverse effects are common and severe effects are also reported. Structured data collected by the NPIS may be of use in identifying trends in poisoning and in establishing toxidromes for new drugs of abuse.

The Toxicology of Bath Salts: A Review of Synthetic Cathinones

“…Prior to 2009, the UK Poisons Information Service had no telephone inquiries related to synthetic cathinones. However over a 1-year period from 2009 to 2010, the number of inquiries regarding synthetic cathinone derivatives equaled the number of calls about cocaine and MDMA [1]. Google Insights, a web application that tracks search terms, shows almost no searches for mephedrone before 2008.…”

Sepsis: recognition and treatment

“…Overall mortality for those admitted with severe sepsis is decreasing through advances in medical care, but it remains unacceptably high (>30%) with approximately 37,000 deaths annually in the UK. 7 In a recent international survey investigating the views of physicians regarding sepsis, 8 86% of responders felt that the symptoms of sepsis could easily be misattributed to other medical conditions, leading to delayed diagnosis and treatment, while 81% felt that a clear, globally accepted clinical definition would help.…”

“…The latter products may appear in different countries under different names. 7 There seem to be at least 150 different chemicals with cannabinoid properties. In overdose they may cause symptoms of extreme cannabis use, but seizures and hypokalaemia are also reported.…”

Drogas emergentes (I): las «smart drugs»

“…La mefedrona (4-metilmetcatinona) es un análogo sintético de la catinona, que se ha convertido en la alternativa legal más popular al éxtasis y la cocaína, por sus propiedades euforizantes y entactógenas, consumiéndose de forma importante en Inglaterra, Suecia y otros países europeos 30 . Es también conocida como MEFE, MET, MIAU, Cat, MIEW MIEW, 4-MMC, entre otras denominaciones (como se observa haciendo referencia al «gato» y su maullido).…”

“…2011, Vol. 34, Nº 2, mayo-agosto confusión, fiebre y mioclonías podría indicar la existencia de cuadros compatibles con un síndrome serotoninérgico 30 .…”